Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Gross Margin (2016 - 2026)

Orthofix Medical has reported Gross Margin over the past 17 years, most recently at 74.98% for Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 802.0% year-over-year to 74.98%, compared with a TTM value of 73.8% through Mar 2026, up 87.0%, and an annual FY2025 reading of 68.83%, down 417.0% over the prior year.
  • Gross Margin came in at 74.98% for Q1 2026, up from 71.09% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 133.19% in Q4 2022 to a low of 65.09% in Q3 2023.
  • Median Gross Margin over the past 5 years was 72.9% (2025), compared with a mean of 78.3%.
  • The sharpest move saw Gross Margin surged 4999bps in 2022, then tumbled -4032bps in 2023.
  • Over 5 years, Gross Margin stood at 133.19% in 2022, then plummeted by -30bps to 92.87% in 2023, then decreased by -2bps to 90.78% in 2024, then dropped by -22bps to 71.09% in 2025, then rose by 5bps to 74.98% in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Gross Margin are 74.98% (Q1 2026), 71.09% (Q4 2025), and 76.63% (Q3 2025).